Hyperthermic intraperitoneal chemotherapy in the treatment for recurrent ovarian cancer
Giseĭnov, K.D.; Beliaev, A.M.; Senchik, K.I.; Maksimov, S.I.; Urmancheeva, A.F.; Gafton, G.I.; Mikaia, N.A.; Beliaeva, O.A.; Kireeva, G.S.; Gorodnova, T.V.; Matveeva, N.S.
Voprosy Onkologii 60(3): 343-347
2014
ISSN/ISBN: 0507-3758 PMID: 25033688 Document Number: 674583
There are presented data of literature and own observations of the treatment for recurrent ovarian cancer using hyperthermic intraperitoneal chemoperfusion. The possible complications during hyperthermic chemoperfusion are discussed and the effectiveness of the method is analyzed. Further studies are needed to obtain more certain criteria for abdominal chemotherapy in these patients.
Document emailed within 1 workday
Related Documents
Wydra, D.; Emerich, J. 2002: Intraperitoneal hyperthermic perfusion chemotherapy in recurrent ovarian cancer Ginekologia Polska 73(11): 1044-1047Robella, M.; Vaira, M.; Marsanic, P.; Mellano, A.; Borsano, A.; Cinquegrana, A.; Sottile, A.; De Simone, M. 2014: Treatment of peritoneal carcinomatosis from ovarian cancer by surgical cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC) Minerva Chirurgica 69(1): 27-35
Samartzis, K.; Thomakos, N.; Liontos, M.; Kollia, D.; Malakasis, A.; Haidopoulos, D.; Bamias, A.; Rodolakis, A.; Loutradis, D. 2018: Is it the right moment to include hyperthermic intraperitoneal chemotherapy as standard in ovarian cancer management? a reappraisal Journal of Buon: Official Journal of the Balkan Union of Oncology 23(7): 19-23
Kocic, M.; Nikolic, S.; Zegarac, M.; Djurisic, I.; Soldatovic, I.; Milenkovic, P.; Kocic, J. 2016: Prognostic factors and outcomes of cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy in patients with advanced ovarian cancer - A single tertiary institution experience Journal of BUON: Official Journal of the Balkan Union of Oncology 21(5): 1176-1183
Lepistö, A. 2016: Novel approved form of treatment for colonic cancer with peritoneal metastases - radicality-aimed surgery combined with hyperthermic intraperitoneal chemotherapy Duodecim; Laaketieteellinen Aikakauskirja 132(10): 912-916
Sherman, A.I.; Rosenberg, R.; Fink, D. 1992: Use of intraperitoneal chemotherapy for treatment of ovarian cancer European Journal of Gynaecological Oncology 13(4): 295-305
Di Miceli, D.; Cina, C.; Fiorillo, C.; Doglietto, G.B.; Alfieri, S. 2018: The hyperthermic intraoperative intraperitoneal chemotherapy in the treatment of advanced abdominopelvic cancer. Personal experience on 103 procedures during a seventeen year period in a single Italian center European Review for Medical and Pharmacological Sciences 22(3): 796-801
Lygidakis, N.J.; Patil, A.; Giannoulis, K.; Fukuda, T.; Kumar, R. 2010: Laparoscopic hyperthermic intraperitoneal chemotherapy as adjuvant modality following radical surgery for advanced rectal cancer a new look to an old problem Hepato-Gastroenterology 57(97): 73-75
Beliaev, A.M. 2003: Hyperthermic intraoperative intraperitoneal chemotherapy in combined treatment of patients with tumors of the abdominal organs Vestnik Khirurgii Imeni I. I. Grekova 162(6): 96-101
Xia, W.; Hu, Y.; Mou, T.; Chen, T.; Yu, J.; Li, G. 2014: Safety and efficacy of intraperitoneal hyperthermic perfusion chemotherapy following laparoscopic palliative resection for gastric cancer patients with peritoneal metastasis Zhonghua Wei Chang Wai Ke Za Zhi 17(11): 1087-1091
Deraco, M.; Kusamura, S.; Gronchi, A. 2003: Cytoreductive surgery (peritonectomy) and intraperitoneal hyperthermic chemotherapy: an innovative and effective approach to the treatment of pseudomyxoma peritonei Tumori 89(4 Suppl): 54-55
Shershah, S. 1985: Treatment by combined chemotherapy for recurrent ovarian cancer JPMA. Journal of the Pakistan Medical Association 35(11): 341-343
Lei, Z.Y.; Guan, T.P.; Luo, J.L.; Tang, H.S.; Cui, S.Z. 2019: Rationality of performing hyperthermic intraperitoneal chemotherapy 5-8 weeks after primary tumor resection for patients with locally advanced colorectal cancer-based on COLOPEC Zhonghua Wei Chang Wai Ke Za Zhi 22(12): 1115-1117
De Gramont, A.; Marpeau, L.; Demuynck, B.; Louvet, C.; Varette, C.; Gonzalez-Canali, G.; Pigné, A.; Herbulot, P.; Lagadec, B.; Cady, J. 1991: Results of intraperitoneal chemotherapy of ovarian cancer Journal de Gynecologie Obstetrique et Biologie de la Reproduction 20(3): 387-392
Miron, L.; Onofriescu, M.; Marinca, M. 2008: Controversies regarding intraperitoneal chemotherapy for advanced ovarian cancer Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 112(3): 583-589
Meng, F.H. 1994: Care of ovarian cancer treated with intraperitoneal chemotherapy Zhonghua Hu Li Za Zhi 29(1): 24-26
Sugiyama, T.; Kumagai, S.; Nishida, T.; Ushijima, K.; Matsuo, T.; Yakushiji, M.; Hyon, S.H.; Ikada, Y. 1998: Experimental and clinical evaluation of cisplatin-containing microspheres as intraperitoneal chemotherapy for ovarian cancer Anticancer Research 18(4b): 2837-2842
Wydra, D.; Sawicki, J.; Sawicki, S.; Ciach, K.; Emerich, J. 2003: Laboratory investigation of flow characteristics during intraperitoneal hyperthermic perfusion chemotherapy Ginekologia Polska 74(9): 918-924
Deng, C.; Huang, R.; Lian, L. 1996: Pharmacokinetic study of intraperitoneal chemotherapy with high-dose cisplatin for advanced ovarian cancer Zhonghua Fu Chan Ke Za Zhi 31(3): 159-162
Mansvelt, B.; Bertrand, C.; Nockerman, P.; Arnould, P.; Delvaux, P.; Lechien, X.; de Neve de Roden, A. 1997: Study of the toxicity and results of intraperitoneal hyperthermic chemotherapy in 28 patients with peritoneal carcinomatosis Annales de Chirurgie 51(1): 60-67